UTAH MEDICAL PRODUCTS INC
For the period ended Jul 25, 2024. Filed Jul 25, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jul 25, 2024 · Filed Jul 25, 2024
UTMD$72.23+1.7%Stored close · as of Nov 6, 2026
Contents
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 25, 2024
| UTAH MEDICAL PRODUCTS, INC. | ||
|---|---|---|
| (Exact name of registrant as specified in its charter) | ||
| Utah | 000-12575 | 87-0342734 |
| (State or other jurisdiction of | (Commission File Number) | (IRS Employer |
| incorporation or organization) | Identification No.) | |
| 7043 South 300 West | ||
| Midvale, Utah | 84047 | |
| (Address of principal executive offices) | (Zip code) | |
| Registrant’s telephone number, including area code: | Phone: (801) 566-1200 | |
| n/a | ||
| (Former name or former address, if changed since last report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter). | |
| Emerging growth company ☐ | |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ] | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.